| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1468-0734.2001.00042.X |
| P698 | PubMed publication ID | 11703819 |
| P2093 | author name string | Rebulla P | |
| P2860 | cites work | Considerations in the selection of a platelet component: apheresis versus whole blood-derived | Q33769745 |
| Cryopreservation of platelets: an in-vitro comparison of four methods | Q33848597 | ||
| Pharmacological therapies to minimise platelet transfusion | Q33930298 | ||
| Additive solutions for the storage of platelets for transfusion | Q34109422 | ||
| Monitoring for underutilization of RBC components and platelets | Q34247834 | ||
| Use of platelets and other transfusion products in patients with malignancy | Q35622088 | ||
| Leukocyte Reduction in Blood Component Therapy | Q36212698 | ||
| Large-volume hemocytometer chamber for accurate counting of white cells (WBCs) in WBC-reduced platelets: validation and application for quality control of WBC-reduced platelets prepared by apheresis and filtration | Q36782350 | ||
| Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions | Q40720707 | ||
| Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions | Q40748675 | ||
| Febrile reactions after platelet transfusion: the effect of single versus multiple donors | Q40764863 | ||
| Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient | Q40783408 | ||
| Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia | Q40830615 | ||
| The management of abnormalities of hemostasis in acute liver failure | Q40921008 | ||
| Disseminated intravascular coagulation: diagnosis and treatment | Q40968013 | ||
| Management of acquired coagulation disorders in emergency and intensive-care medicine | Q41035449 | ||
| In vitro assessment of platelet function | Q41461707 | ||
| The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study | Q43589291 | ||
| LAV/HTLV-III plays a dominant role in the etiology of AIDS. | Q43983171 | ||
| Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood | Q44214202 | ||
| Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood | Q44235985 | ||
| Role of acetate during platelet storage in a synthetic medium | Q44326607 | ||
| Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr | Q44905257 | ||
| Storage of apheresis platelets after gamma radiation | Q45088430 | ||
| Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis | Q45249393 | ||
| Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration | Q45843417 | ||
| Unexpected bleeding disorders: Algorithm for approach to therapy | Q45875727 | ||
| Transfusion-associated graft-versus-host disease in an immunocompetent patient. | Q46032573 | ||
| Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers. | Q52866928 | ||
| A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. | Q53369345 | ||
| The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets. | Q53539667 | ||
| Trigger factors for prophylactic platelet transfusion. | Q53558686 | ||
| High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure. | Q54130306 | ||
| Platelet cryopreservation using a combination of epinephrine and dimethyl sulfoxide as cryoprotectants | Q57107274 | ||
| Hemostatic drugs | Q28277099 | ||
| Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex | Q31974821 | ||
| The rational use of platelet transfusions in children | Q33328048 | ||
| A practical approach to the diagnosis and management of thrombocytopenia associated with glycoprotein IIb/IIIa receptor inhibitors | Q33331054 | ||
| Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study. | Q33332057 | ||
| Management of thrombotic thrombocytopenic purpura | Q33333063 | ||
| Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. | Q33334908 | ||
| Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology | Q33336231 | ||
| Automated CD61 immunoplatelet analysis of thrombocytopenic samples | Q33336456 | ||
| Lowering the prophylactic platelet transfusion threshold: a prospective analysis | Q33337229 | ||
| Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force | Q33351618 | ||
| The quantitative relation between platelet count and hemorrhage in patients with acute leukemia | Q33353564 | ||
| A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters | Q33362930 | ||
| Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia | Q33371869 | ||
| Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities | Q33393636 | ||
| The significance of thrombocytopenia in the development of postoperative intracranial hematoma | Q33433701 | ||
| Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients | Q33455050 | ||
| The Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind Study | Q33465206 | ||
| Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia | Q33475632 | ||
| Thrombocytopenia and gastrointestinal hemorrhage in the cancer patient: prevalence of unmasked lesions | Q33479855 | ||
| Frozen autologous platelet transfusion for patients with leukemia | Q33479975 | ||
| Indications for platelet transfusion in children with acute leukemia | Q33483256 | ||
| Human platelets frozen with glycerol in liquid nitrogen: biological and clinical aspects | Q33486221 | ||
| Platelet transfusion therapy in newborn infants | Q33488344 | ||
| Complications of fiberoptic bronchoscopy in thrombocytopenic patients | Q33494147 | ||
| Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies | Q33494715 | ||
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Q33501152 | ||
| Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions | Q33501221 | ||
| Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits | Q33504864 | ||
| Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective | Q33581221 | ||
| Single donor platelets: can we afford to use them? Can we afford not to use them? | Q33581227 | ||
| P433 | issue | 3 | |
| P921 | main subject | clinical indication | Q110971784 |
| P304 | page(s) | 288-310; discussion 311-2 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Reviews in Clinical and Experimental Hematology | Q15753090 |
| P1476 | title | Revisitation of the clinical indications for the transfusion of platelet concentrates | |
| P478 | volume | 5 |
| Q39179984 | Bio-inspired nanomedicine strategies for artificial blood components |
| Q36450179 | Clinical profile of concurrent dengue fever and Plasmodium vivax malaria in the Brazilian Amazon: case series of 11 hospitalized patients |
| Q33401660 | Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study |
| Q33428440 | Endoscopy in neutropenic and/or thrombocytopenic patients |
| Q28288397 | Evaluation of platelet transfusion triggers in a tertiary-care hospital |
| Q38282573 | Perioperative considerations of the patient with malaria |
| Q33401247 | Platelet usage trends in a tertiary care hospital - Could it be less and less expensive? |
| Q45130858 | Platelet-released supernatant increases matrix metalloproteinase-2 production, migration, proliferation, and tube formation of human umbilical vascular endothelial cells |
| Q34988663 | Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
Search more.